Korean researchers tested the ability of radiologists to spot CT images altered with commercially available software to introduce pathology and found that their skill at doing so is no more certain than a coin flip.
Korean researchers tested the ability of radiologists to spot CT images altered with commercially available software to introduce pathology and found that their skill at doing so is no more certain than a coin flip. Researchers from the Catholic University of Korea designed a test to find out how well 17 attending radiologists and 13 residents could spot images with faked and real pathology in a set of 10 images. After being told that some of the images were digitally altered, the attending radiologists were able to spot the five fakes only 51.8% of the time. Residents spotted the fakes just 47.7% of the time. “The recognition of retouched images was like coin flipping,” said Catholic University’s Hee Jae Chang, who presented the study at the 2009 RSNA meeting. For more details about the study (abstract No. SSQ10-04), along with comments from the audience and moderators, go to Diagnostic Imaging’s RSNA 2009 conference reporter at diagnosticimaging.com. The article was posted Dec. 4. And, so you know, the one on the bottom is the altered image.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.